about
Spinal cord tumours: advances in genetics and their implications for treatmentPromotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles.Transdermal deferoxamine prevents pressure-induced diabetic ulcers.A regulatory feedback loop between HIF-1α and PIM2 in HepG2 cellsThe von Hippel-Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoformShort Hairpin RNA Silencing of PHD-2 Improves Neovascularization and Functional Outcomes in Diabetic Wounds and Ischemic LimbsPropranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patientsTie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus.Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Novel homozygous VHL mutation in exon 2 is associated with congenital polycythemia but not with cancer.Clinical utility gene card for: von Hippel-Lindau (VHL).Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.Neurocutaneous Syndromes and Brain Tumors.(1)H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism.HIF1-regulated ATRIP expression is required for hypoxia induced ATR activation.LPS-Induced ex vivo Cytokine Production is Not Augmented in Patients with Von Hippel-Lindau Disease.Recent Advances in Intradural Spinal Tumors.Beta-2-glycoprotein-1 and alpha-1-antitrypsin as urinary markers of renal cancer in von Hippel-Lindau patients.Fibroblast-Specific Deletion of Hypoxia Inducible Factor-1 Critically Impairs Murine Cutaneous Neovascularization and Wound Healing.Pedigree analysis, diagnosis and treatment in Von Hippel-Lindau syndrome: A report of three cases.
P2860
Q26851596-D1434432-F3AD-4C2C-9DB8-F72C1077720AQ33572498-FE85DB63-67E7-4E61-9225-E330DA21A839Q34926164-1DA38E23-D17E-4886-9822-557BB594813EQ35088674-3114E40F-77A7-47F9-ACAE-7A8FA5B807E7Q35863138-F0A85B6D-DE01-48CE-90BC-37993F081AF8Q35954187-C733DAA4-97C3-4052-890E-D91F16005428Q36084905-2CD92AA5-280B-48B3-9E18-EA49372EB278Q37142182-B2259D08-D76D-4E7E-8CBA-11F1676FDFBDQ37236103-89158F5C-5C0A-4292-89AB-C6B1752946B6Q37685596-6D77B6DF-5794-4642-89AF-C6E9424CDA49Q38271566-08A8C4E1-814D-43CD-937F-AF6D24116A41Q38595266-EE2C695C-6E97-45CD-B473-AF01D953C09BQ38605389-663CAEA5-2C57-4202-B233-76DFD3875492Q38815713-4D181BE8-0E9A-4B71-A5A8-4036C522382CQ39186453-C88E34E7-1C99-4270-90F9-BA3F433340AAQ48181392-476E6D37-6451-4CF1-8CC1-0D705CAE7091Q50027408-F4E42E0C-8C2F-4F14-8BE1-D2F5729FF642Q51242887-51E80A04-AB7C-40C6-8431-00C9CB89B5CDQ53298814-A36A5432-71AD-4808-BADF-8F80B3850213Q55155519-EE6CF6AE-75B2-40ED-B716-085BEEE0DEEA
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Systemic VHL gene functions and the VHL disease
@ast
Systemic VHL gene functions and the VHL disease
@en
Systemic VHL gene functions and the VHL disease
@nl
type
label
Systemic VHL gene functions and the VHL disease
@ast
Systemic VHL gene functions and the VHL disease
@en
Systemic VHL gene functions and the VHL disease
@nl
prefLabel
Systemic VHL gene functions and the VHL disease
@ast
Systemic VHL gene functions and the VHL disease
@en
Systemic VHL gene functions and the VHL disease
@nl
P2860
P921
P1433
P1476
Systemic VHL gene functions and the VHL disease
@en
P2093
Hannah L Bader
P2860
P304
P356
10.1016/J.FEBSLET.2012.04.032
P407
P50
P577
2012-04-25T00:00:00Z